Association of Kidney and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus: Insights From the EMPA-REG OUTCOME Trial - 31/07/21
Doi : 10.1016/j.hlc.2021.06.259
A. Hamilton 1, A. Sharma 2, S. Inzucchi 3, J. Testani 4, A. Ofstad 5, D. Fitchett 6, M. Mattheus 7, S. Verma 8, F. Zannad 9, C. Wanner 10, B. Kraus 10, 11, 12
1 Nightingale Cardiology, Adelaide, Australia
2 McGill University Health Centre, Montreal, Québec, Canada
3 Section of Endocrinology, Yale University School of Medicine, New Haven, CT, United States of America
4 Department of Internal Medicine, Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, CT, USA
5 Boehringer Ingelheim Norway KS, Asker, Norway
6 St Michael's Hospital, Division of Cardiology, University of Toronto, Toronto, Ontario, Canada
7 Boehringer Ingelheim Pharma GmbH & Co KG, Würzburg, Germany
8 St. Michael’s Hospital, Division of Cardiac Surgery, University of Toronto, Toronto, Ontario, Canada
9 Université de Lorraine, INSERM, Centre d'Investigations Cliniques Plurithématique 1433, INSERM 1116, CHRU de Nancy, FCRIN INI-CRCT, Nancy, France
10 Department of Internal Medicine I, University Hospital Würzburg, Würzburg, Germany
11 Boehringer Ingelheim International GmbH, Ingelheim, Germany
12 Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany
256
Le texte complet de cet article est disponible en PDF.Plan
© 2021
Publié par Elsevier Masson SAS.
Vol 30 - N° S3
P. S212-S213 - 2021 Retour au numéro
Article précédent
- This abstract has been withdrawn
- Associations Between DAPT Score and Long-term Mortality Post PCI
- M. Tan, D. Dinh, D. Gayed, D. Liang, A. Brennan, S. Duffy, D. Clark, A. Ajani, E. Oqueli, L. Roberts, C. Reid, M. Freeman, J. Chandrasekhar
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?